Clinical Trial Update: A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Anaprazole Sodium Enteric-coated Tablets in reflux esophagitis (reflux esophagitis/gastroesophageal reflux).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux
• Reflux Esophagitis

Drugs mentioned

• Anaprazole Sodium Enteric-coated Tablets (anaprazole sodium)

Snippet

Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. | Conditions: Reflux Esophagitis, Gastroesophageal Reflux | Phase 2 | Status: UNKNOWN